Research Article

Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk

Volume: 9 Number: 2 December 18, 2025
EN TR

Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk

Abstract

In our study, the probiotic, exopolysaccharide, metabolite contents, antioxidant activities, and anticancer activities of metabolites on HT-29 and Caco-2 cell lines of four Levilactobacillus brevis (YAAS1, YAAS2, YAAS3, and YAAS4) strains isolated from breast milk in Türkiye and identified by MALDI-TOF MS were investigated. It was determined that the strains exhibited strong probiotic character by surviving in pH+pepsin, bile and pancreatin medium; although, they decreased depending on time and concentration. The strains synthesized the most acetic acid but could not synthesize tartaric, pyruvic, malic, and fumaric acids. It was determined qualitatively and quantitatively that the strains synthesized compounds similarly in terms of exopolysaccharide amount. The strains exhibited lower DPPH activity than standard antioxidants. However, ABTS activities were similar to standard antioxidants. Bacterial metabolites induced notable anticancer effects in the HT-29 cell line at low concentrations, while eliciting comparable effects in the Caco-2 cell line at high concentrations. When all the results were considered in general, it was determined that the strains showed identical properties to each other but L. brevis YAAS4 strain exhibited a better character structure. Given the scarcity of studies on Lactobacillus brevis strains newly isolated from human breast milk, this research significantly advances current understanding. Characterizing the specific properties identified in our study through future research will be crucial for determining the potential of these isolates as effective probiotics for industrial and health applications.

Keywords

Ethical Statement

Ethical approval for this study was obtained from the Ethics Committee of Van Eğitim ve Araştırma Hastanesi for Clinical Research (28.09.2017, No: 2017/7).

References

  1. Alameri, F., Tarique, M., Osaili, T., Obaid, R., Abdalla, A., Masad, R., & Ayyash, M. (2022). Lactic acid bacteria isolated from fresh vegetable products: potential probiotic and postbiotic characteristics including immunomodulatory effects. Microorganisms, 10(2), 389. https://doi.org/10.3390/microorganisms10020389
  2. Alan, Y. (2024). Chemical changes of potential probiotic Lactiplantibacillus plantarum and Lactobacillus pentosus starter cultures in natural Gemlik type black olive fermentation. Food Chemistry, 434, 137472. https://doi.org/10.1016/j.foodchem.2023.137472
  3. Alan, Y., Savcı, A., Koçpınar, E.F., & Ertaş, M. (2022). Postbiotic metabolites, antioxidant and anticancer activities of probiotic Leuconostoc pseudomesenteroides strains in natural pickles. Archives of Microbiology, 204(9), 571. https://doi.org/10.1007/s00203-022-03180-6
  4. Alan, Y., Keskin, A.O., & Sönmez, M. (2025). Probiotic and functional characterization of newly isolated Lactiplantibacillus plantarum strains from human breast milk and proliferative inhibition potential of metabolites. Enzyme and Microbial Technology, 182, 110545. https://doi.org/10.1016/j.enzmictec.2024.110545
  5. Albesharat, R., Ehrmann, M.A., Korakli, M., Yazaji, S., & Vogel, R. F. (2011). Phenotypic and genotypic analyses of lactic acid bacteria in local fermented food, breast milk and faeces of mothers and their babies. Systematic and Applied Microbiology, 34(2), 148-155. https://doi.org/10.1016/j.syapm.2010.12.001
  6. Angelin, J., & Kavitha, M. (2020). Exopolysaccharides from probiotic bacteria and their health potential. International journal of biological macromolecules, 162, 853-865. https://doi.org/10.1016/j.ijbiomac.2020.06.190
  7. Anjum, J., Nazir, S., Tariq, M., Barrett, K., & Zaidi, A. (2020). Lactobacillus commensals autochthonous to human milk have the hallmarks of potent probiotics. Microbiology, 166, 966-980. https://doi.org/10.1099/mic.0.000966
  8. Assaf, A.M., Haddadin, R.N., Aldouri, N.A., Alabbassi, R., Mashallah, S., Mohammad, M., & Bustanji, Y. (2013). Anti-cancer, anti-inflammatory and anti-microbial activities of plant extracts used against hematological tumors in traditional medicine of Jordan. Journal of Ethnopharmacology, 145(3), 728-736.

Details

Primary Language

English

Subjects

Bacteriology, Microbiology (Other)

Journal Section

Research Article

Early Pub Date

June 30, 2025

Publication Date

December 18, 2025

Submission Date

March 18, 2025

Acceptance Date

May 15, 2025

Published in Issue

Year 2025 Volume: 9 Number: 2

APA
Alan, Y., & Ertaş, M. (2025). Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk. Commagene Journal of Biology, 9(2), 123-132. https://doi.org/10.31594/commagene.1660124
AMA
1.Alan Y, Ertaş M. Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk. Comm. J. Biol. 2025;9(2):123-132. doi:10.31594/commagene.1660124
Chicago
Alan, Yusuf, and Metin Ertaş. 2025. “Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus Brevis Strains Newly Isolated from Breast Milk”. Commagene Journal of Biology 9 (2): 123-32. https://doi.org/10.31594/commagene.1660124.
EndNote
Alan Y, Ertaş M (December 1, 2025) Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk. Commagene Journal of Biology 9 2 123–132.
IEEE
[1]Y. Alan and M. Ertaş, “Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk”, Comm. J. Biol., vol. 9, no. 2, pp. 123–132, Dec. 2025, doi: 10.31594/commagene.1660124.
ISNAD
Alan, Yusuf - Ertaş, Metin. “Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus Brevis Strains Newly Isolated from Breast Milk”. Commagene Journal of Biology 9/2 (December 1, 2025): 123-132. https://doi.org/10.31594/commagene.1660124.
JAMA
1.Alan Y, Ertaş M. Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk. Comm. J. Biol. 2025;9:123–132.
MLA
Alan, Yusuf, and Metin Ertaş. “Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus Brevis Strains Newly Isolated from Breast Milk”. Commagene Journal of Biology, vol. 9, no. 2, Dec. 2025, pp. 123-32, doi:10.31594/commagene.1660124.
Vancouver
1.Yusuf Alan, Metin Ertaş. Determination of Antioxidant and Anticancer Activities and Exopolysaccharides of Metabolites Synthesized by Probiotic Levilactobacillus brevis Strains Newly Isolated from Breast Milk. Comm. J. Biol. 2025 Dec. 1;9(2):123-32. doi:10.31594/commagene.1660124